Gerresheimer, an innovative system and solution provider and a global partner for the pharma, biotech and cosmetic industries, decisively continued on its profitable growth course in the financial year 2023 with an organic revenue growth of 10.4% and a strong adjusted EBITDA growth of 17.5%. Revenues reached €1.99bn (2022: €1.82bn), the adjusted EBITDA €404.5m (2022: €354.2m).
Butterworth Laboratories, a company providing contract analytical chemistry services to global pharmaceutical and life sciences companies, will be exhibiting at this year's Making Pharmaceuticals conference taking place from 23-24 April in Coventry, UK.
Gerresheimer, an innovative system and solution provider and a global partner for the pharma, biotech and cosmetic industry, will present its comprehensive portfolio of containment solutions, drug delivery systems and digital solutions in areas such as therapy support at this year’s Pharmapack. The company’s presence at the trade fair will focus on specialised primary packaging solutions for sensitive innovative drugs such as biopharmaceuticals, including cell and gene therapy products — from COP injection vials for cryogenic temperatures through to medication pumps.
Gerresheimer, an innovative systems and solutions provider and global partner for the pharma, biotech and cosmetics industries, and Aptar Digital Health, a global expert in Software as a Medical Device (SaMD), digital Patient Support Programmes (PSPs) and disease management solutions, collaborate to develop an integrated solution for cancer therapy management. As part of this collaboration, the Gx SensAir on-body drug delivery device will be connected to Aptar Digital Health's software-as-a-medical device platform to improve the treatment experience and outcomes of cancer patients.
Gerresheimer, the innovative system and solution provider and global partner to the pharma, biotech and cosmetics industries, has signed a long-term electricity supply agreement with PNE, an international project planning company and wind turbine operator. The power purchase agreement (PPA), which covers around 35GWh of wind power per year, will enable Gerresheimer to reduce its CO₂ emissions by around 18,000t* each year starting in 2024.
Significant expansion of production capacities for RTF syringes for the North American market - investment volume of around €100m
Tosoh Bioscience, a renowned leader in the field of chromatography, announced the recent publication of a groundbreaking paper titled 'Separation of Full and Empty AAV Capsids by Anion-Exchange Chromatography Using Choline-Type Salts'. The research, made accessible to the scientific community through SSRN/Elsevier as a pre-print publication, spotlights an innovative analytical method for professionals working with adeno-associated viruses (AAVs) that ensures a safer working environment and environmental protection. The method uses non-toxic choline chloride for the separation of empty and full AAV capsids, marking a significant improvement in comparison with the traditionally used, and highly toxic, tetramethylammonium chloride (TMAC).
Gerresheimer, an innovative provider of systems and solutions and a global partner for the pharma, biotech and cosmetic industries, has once again been awarded Gold status by the ratings agency EcoVadis. EcoVadis assesses the performance of businesses on environmental, labour and human rights, ethical, and sustainable procurement criteria.
RWS, a company providing translation services for pharmaceutical and life sciences companies, is exhibiting at the CAHP conference in Palm Desert, California, this month. To be held from 23-25 October, the event will be the 37th edition of the annual conference.
Gerresheimer, innovative system and solution provider and global partner for the pharma and biotech industry launches with COP (Cyclic Olefin Polymer) vials a particularly satisfactory solution for the filling and storage of highly sensitive biologics. They are suitable for mRNA active ingredients at -80°C and cryogenic temperatures.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.